Researchers sought to determine whether there was a possible severe reaction following COVID-19 vaccination in patients with paroxysmal nocturnal hemoglobinuria.
Investigators discuss surgical approaches and outcomes of total and partial splenectomy for the treatment of hereditary hemolytic anemia in children.
Patients with autoimmune hemolytic anemia who underwent splenectomy experienced increased cumulative incidences of thromboembolism and sepsis.
Thrombotic events and sepsis occurred more frequently in patients who underwent splenectomy and were additionally associated with increased mortality risk.
Patients with secondary Evans syndrome demonstrated increased mortality compared with all other cohorts.
Researchers assessed the predictive value of various laboratory parameters for iron overload in patients with congenital hemolytic anemias.
Immune checkpoint inhibitor (ICI) therapy may lead to autoimmune hemolytic anemia (AIHA), but diagnosis of AIHA may not necessitate ICI discontinuation.
Patients who received sutimlimab experienced meaningful increases in hemoglobin levels and normalization of bilirubin levels.
Eculizumab has been used to treat paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
